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Background: Our previous work showed that providing additional rehabilitation on a Saturday was cost effective in
the short term from the perspective of the health service provider. This study aimed to evaluate if providing additional
rehabilitation on a Saturday was cost effective at 12 months, from a health system perspective inclusive of private costs.
Methods: Cost effectiveness analyses alongside a single-blinded randomized controlled trial with 12 months follow up
inclusive of informal care. Participants were adults admitted to two publicly funded inpatient rehabilitation facilities. The
control group received usual care rehabilitation services from Monday to Friday and the intervention group received
usual care plus additional Saturday rehabilitation. Incremental cost effectiveness ratios were reported as cost per quality
adjusted life year (QALY) gained and for a minimal clinical important difference (MCID) in functional independence.
Results: A total of 996 patients [mean age 74 years (SD 13)] were randomly assigned to the intervention (n = 496) or
control group (n = 500). The intervention was associated with improvements in QALY and MCID in function, as well as
a non-significant reduction in cost from admission to 12 months (mean difference (MD) AUD$6,325; 95% CI −4,081 to
16,730; t test p = 0.23 and MWU p = 0.06), and a significant reduction in cost from admission to 6 months (MD
AUD$6,445; 95% CI 3,368 to 9,522; t test p = 0.04 and MWU p = 0.01). There is a high degree of certainty that providing
additional rehabilitation services on Saturday is cost effective. Sensitivity analyses varying the cost of informal carers
and self-reported health service utilization, favored the intervention.
Conclusions: From a health system perspective inclusive of private costs the provision of additional Saturday
rehabilitation for inpatients is likely to have sustained cost savings per QALY gained and for a MCID in functional
independence, for the inpatient stay and 12 months following discharge, without a cost shift into the community.
Trial registration: Australian and New Zealand Clinical Trials Registry November 2009 ACTRN12609000973213.
Keywords: Rehabilitation, Economic evaluation, Randomized controlled trial, Allied healthBackground
The role of rehabilitation within a health service is to
achieve and maintain optimal functioning for the patient
[1]. Rehabilitation services are available across a variety of
settings including acute hospitals, inpatient rehabilitation
facilities or in the community [1,2]. There is emerging evi-
dence of short term clinical and economic gains for the* Correspondence: nbrusco@cabrini.com.au
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unless otherwise stated.provision of additional weekend rehabilitation services for
inpatients including likely cost savings associated with a
reduction in hospital length of stay, as well as higher func-
tional status and improved quality of life on discharge
from rehabilitation [3,4].
There is an important distinction between achieving
short term gains following an intervention and sustain-
ing these gains over the medium and longer term [5].
The success of rehabilitation may initially focus on the
point of discharge from the rehabilitation program, but
there is also value in evaluating the sustainability of this
success. Measuring success for inpatient rehabilitation
may include reporting gains in functional status or qualityThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a broader view that reports the ability to return to the
community, participate in the workforce and resume usual
societal roles [6]. No matter the viewpoint, sustainability
of the intervention is an important consideration to meas-
uring the success of inpatient rehabilitation.
Another consideration in measuring the success and
sustainability of rehabilitation is understanding the re-
source impact on the health system and the broader com-
munity beyond discharge from the rehabilitation facility.
In the 12 months following discharge from rehabilitation,
patients have a high rate of health care and community re-
source use, such as readmission to inpatient health ser-
vices, visits to allied health professionals, and the use of
informal care which can increase the burden on the com-
munity [7,8]. An economic evaluation limited to the per-
spective of the inpatient rehabilitation facility will miss the
ongoing health and community resources utilized once
the patient has been discharged to the community. Taking
a broader health system perspective inclusive of private
costs and a longer follow up period will capture these add-
itional resources.
Providing additional Saturday rehabilitation is likely to
be cost saving per quality adjusted life year (QALY)
gained and for a minimal clinical important difference
(MCID) in functional independence from the perspective
of the individual health service including the 30 day
period following discharge [3]. However, the resource
impact on the broader health system is not known in the
12 month period following discharge and whether the
cost and clinical outcome results favoring additional Sat-
urday rehabilitation are sustained in the medium and
longer term. The aim of this study was to determine
from a health system perspective inclusive of private
costs if the likely short-term cost effectiveness of provid-
ing an additional Saturday rehabilitation service to inpa-
tients in addition to Monday to Friday compared to
Monday to Friday rehabilitation alone, is sustained
12 months following discharge from rehabilitation.
Methods
Research design and intervention
An economic evaluation alongside a randomized con-
trolled trial from a health system perspective inclusive of
private costs from admission until 12 months following
discharge, was completed comparing usual care Monday
to Friday rehabilitation to Monday to Saturday rehabili-
tation. Saturday rehabilitation consisted of a one hour
scheduled Physiotherapy session and a one hour sched-
uled Occupational Therapy session. Full details of the
protocol [9], the clinical outcomes [4] and an economic
evaluation of the clinical trial with a 30 day follow up
period from the perspective of the health service [3]
have been published elsewhere. The trial was registeredwith the Australian and New Zealand Clinical Trials Regis-
try (ACTRN12609000973213) prior to patient recruitment.
This economic evaluation follows the recommendations of
the Consolidated Health Economic Evaluation Reporting
Standards (CHEERS) Checklist [10].
The economic evaluation has taken a health system per-
spective inclusive of private costs. Out-of-pocket costs for
access to medical, non-medical services and pharmaceuti-
cals have been included in this analysis. Informal care was
also included on the assumption that its availability meant
that health system costs were reduced. For example, with-
out the availability of informal care at discharge, length of
stay may have increased, or patients may have been dis-
charged with additional formal community-based health
services. We do not consider this economic evaluation to
be from a broader societal perspective as productivity
changes have not been incorporated.
Participants, recruitment and setting
Recruitment occurred from July 2010 until June 2011
and participants were included if they were 18 years or
older and required acute inpatient rehabilitation at one
of the two facilities participating in the trial [9]. The eco-
nomic analysis included the initial rehabilitation admis-
sion and had a primary endpoint 12 months following
discharge from rehabilitation, with an interim endpoint
6 months following discharge from rehabilitation.
Administrative data
Administrative data were obtained from the primary
health service for the initial rehabilitation admission and
for any admission in the period 12 months following dis-
charge. The data were at the individual level and in-
cluded the reason for admission, diagnosis related group
(DRG), length of stay, as well as resource use and cost. In
addition, data from Medicare for medical services and
pharmaceuticals (Pharmaceutical Benefits Scheme (PBS))
were obtained for each consenting participant for the 12
months following discharge (Tables 1 and 2).
Health service utilization questionnaire
As the administrative data were limited to acute epi-
sodes (including acute phase rehabilitation) for the pri-
mary health service and non-hospital health care for
Medicare (for example medical and pharmaceuticals), a
self-reported health service utilization questionnaire was
designed to supplement these data (Additional file 1).
The questionnaire was completed for participants at 6
and 12 months following discharge from rehabilitation,
administered by assessors blinded to group allocation.
Participants reported admissions and length of stay of
acute or rehabilitation hospital admissions in facilities
outside of the primary health service, as well as primary
care. There were no double counting of Medicare and
Table 1 Cost variables, resources used and average cost per patient for the control group and the intervention group for the period between the initial
inpatient admission and 12 months following discharge (AUD$2012/13)
Mean resource utilization
per patient for the period
between the initial inpatient
admission and 12 months
following discharge
(SD; range)a
Mean cost per patient for
the period between the
initial inpatient admission











(n = 496) (n = 500) (n = 496) (n = 500)
Initial inpatient rehabilitation
admission (length of stay)
21.2 23.1 13,320 14,302 −1.9 −981
(15.7; 4 to 144) (20.2; 1 to 236) (10,041; 2,652 to 93,095) (12,168; 1,459 to 137,387) (−4.1 to 0.4) (−2,408 to 445)
Hospital readmissions in primary
health service (length of stay)
10.3 15.2 10,283 13,122 −4.9* −2,838
(24.5; 0 to 156) (37.4; 0 to 260) (24,105; 0 to 195,939) (30,255; 0 to 212,390) (−9.0 to −0.9) (−6,340 to 664)
Hospital readmissions in other
health services (length of stay)
2.4 2.9 2364 2829 −0.6 −465
(12.6; 0 to 63) (7.9; 0 to 175) (8013; 0 to 67,095) (12,146; 0 to 169,419) (−1.9 to 0.8) (−1,790 to 859)
Total Medicare claims 50.1 52.7 3,029 3,108 −2.6 −79
(45.8; 0 to 282) (58.4; 0 to 735) (3,704; 0 to 30,129) (4,369; 0 to 53,232) (−9.3 to 4.2) (−598 to 439)
Benefit paid 2,567 2,684 −117
(2,533; 0 to 17,643) (3,037; 0 to 36,847) (−469 to 235)
Out-of-pocket 462 424 38
(1,409; 0 to 12,845) (1,620; 0 to 18,647) (−157 to 232)
Total non-Medicare health care visits 27.0 29.8 1,479 1,669 −2.7 −190
(49.1; 0 to 375) (58.8; 0 to 759) (3,016; 0 to 29,534) (4,174; 0 to 59,634) (−9.6 to 4.1) (−642 to 262)
Physiotherapists 13.8 14.1 670 685 −0.3 −15
(26.4; 0 to 360) (21.4; 0 to 224) (1,281; 0 to 17,460) (1,037; 0 to 10,864) (−3.4 to 2.8) (−164 to 134)
Occupational therapists 2.5 2.9 105 122 −0.4 −17
(9.9; 0 to 94) (10.2; 0 to 128) (417; 0 to 3,975) (433; 0 to 5,413) (−1.7 to 0.9) (−71 to 38)
Other allied health 4.6 4.7 217 223 −0.1 −6
(15.0; 0 to 156) (15.2; 0 to 169) (701; 0 to 7,335) (712; 0 to 7,946) (−2.0 to 1.8) (−96 to 84)
Community nurse 6.1 8.0 487 639 −1.9 −152
(30.6; 0 to 364) (48.6; 0 to 732) (2,439; 0 to 29,007) (3,869; 0 to 58,333) (−4.6 to 0.7) (−363 to 59)
Total pharmaceuticals (PBS) claims 55.9 61.1 2,368 2,558 −5.2 −190














Table 1 Cost variables, resources used and average cost per patient for the control group and the intervention group for the period between the initial
inpatient admission and 12 months following discharge (AUD$2012/13) (Continued)
Benefit paid 2,074 2,256 −182
(2,678; 0 to 37,183) (3,388; 0 to 48,093) (−564 to 200)
Out-of-pocket 294 302 −8
(212; 0 to 1,411) (196; 0 to 1,314) (−34 to 18)
Over-the-counter medications 3.0 3.0 81 72 0.04 9
(2.8; 0 to 16) (2.9; 0 to 15) (152; 0 to 2,084) (105; 0 to 999) (−0.3 to 0.4) (−8 to 26)
Formal (paid) carers (hours) 22.3 21.6 764 740 0.7 24
(58.5; 0 to 494) (52.0; 0 to 408) (2,002; 0 to 16,915) (1,781; 0 to 13,970) (−6.3 to 7.7) (−217 to 265)
Informal (unpaid) carers (hours) 822.7 869.8 28,170 29,784 −47.1 −1,614
(2,025; 0 to 9,906) (52.0; 0 to 11,232) (69,351; 0 to 339,181) (69,902; 0 to 384,584) (−180 to 86) (−6,160 to 2,933)
Total 61,859 68,184 −6,325
(79,798; 4,845 to 463,656) (82,922; 4,845 to 463,656) (−16,730 to 4,081)
t-test p = 0.234
MWU p = 0.056
Sources of price information: hospital admissions in primary health service: variable cost; hospital admissions in other health services; acute hospital $1,065/night, rehabilitation hospital $751/night; Medicare claims:
variable; physiotherapy: $48.50/visit b; occupational therapy: $42.29/visit bspeech therapy: $46.59/visit bother allied health: $47.02/visit bcommunity nurse: $79.69/visit bPharmaceutical Benefits Scheme (PBS) claims:
variable; over-the-counter medications: variable; formal and informal carers: $34.24/hourb.














Table 2 Cost variables, resources used and average cost per patient for the control group and the intervention group for the period between the initial
inpatient admission and 6 months following discharge (AUD$2012/13)
Mean resource utilization
per patient for the period
between the initial inpatient
admission and 6 months
following discharge (SD; range)a
Mean cost per patient for the
period between the initial











(n = 496) (n = 500) (n = 496) (n = 500)
Initial inpatient rehabilitation
admission (length of stay)
21.2 23.1 13,320 14,302 −1.9 −981
(15.7; 4 to 144) (20.2; 1 to 236) (10,041; 2,652 to 93,095) (12,168; 1,459 to 137,387) (−4.1 to 0.4) (−2,408 to 445)
Hospital readmissions in primary
health service (length of stay)
5.8 9.5 5,550 8,019 −3.6* −2,469*
(17.1; 0 to 144) (26.8; 0 to 195) (15,084; 0 to 167,322) (21,529; 0 to 176,202) (−6.5 to −0.7) (−4,849 to −1,214)
Hospital readmissions in other
health services (length of stay)
1.3 1.8 1,360 1,717 −0.5 −357
(5.7; 0 to 63) (9.7; 0 to 160) (5,912; 0 to 67,095) (9,215; 0 to 157,840) (−1.4 to 0.5) (−1,319 to 606)
Total Medicare claims 17.5 16.7 1,059 975 0.8 84
(24.7; 0 to 194) (22.3; 0 to 191) (2,102; 0 to 24,019) (1,897; 0 to 26,724) (−2.3 to 3.8) (−173 to 340)
Benefit paid 881 835 46
(1,393; 0 to 12,932) (1,266; 0 to 11,689) (−121 to 214)
Out-of-pocket 178 140 37
(836; 0 to 11,087) (823; 0 to 15,035) (−69 to 144)
Total non-Medicare health care visits 17.2 18.4 934 1,022 −1.3 −89
(32.5; 0 to 380) (33.5; 0 to 369) (1,911; 0 to 17,370) (2,264; 0 to 29,304) (−5.5 to 3.0) (−357 to 180)
Physiotherapists 9.0 9.1 439 441 −0.1 −3
(16.3; 0 to180) (13.2; 0 to 108) (788; 0 to 8,730) (638; 0 to 5,238) (−1.9 to 1.8) (−94 to 89)
Occupational therapists 1.9 2.1 82 90 −0.2 −8
(8.3; 0 to 140) (7.3; 0 to 72) (351; 0 to 5,921) (308; 0 to 3,045) (−1.2 to 0.8) (−50 to34)
Other allied health 2.5 2.6 116 120 −0.1 −4
(9.2; 0 to 100) (9.4; 0 to 88) (432; 0 to 4,659) (442; 0 to 4,138) (−1.3 to 1.1) (−60 to 52)
Community nurse 3.7 4.7 297 371 −0.9 −74
(18.3; 0 to 182) (25.4; 0 to 366) (1,462; 0 to 14,504) (2,027; 0 to 29,167) (−4.0 to 2.1) (−268 to 120)
Total pharmaceuticals (PBS) claims 28.6 31.4 1,246 1,325 −2.8 −79














Table 2 Cost variables, resources used and average cost per patient for the control group and the intervention group for the period between the initial
inpatient admission and 6 months following discharge (AUD$2012/13) (Continued)
Benefit paid 1,087 1,168 −81
(1,608; 0 to 37,183) (1,810; 0 to 48,093) (−193 to 31)
Out-of-pocket 158 157 2
(126; 0 to 1,411) (114; 0 to 1,314) (−14 to 17)
Over-the-counter medications 1.4 1.5 39 37 −0.01 2
(1.5; 0 to 8) (1.5; 0 to 8) (80; 0 to 1,117) (67; 0 to 931) (−0.2 to 0.2) (−7 to 12)
Formal (paid) carers (hours) 11.3 11.2 388 385 0.1 3
(32.5; 0 to 247) (27.1; 0 to 182) (1,113; 0 to 8,457) (929; 0 to 6,232) (−3.7 to 3.9) (−128 to 134)
Informal (unpaid) carers (hours) 387.7 462.4 13,274 15,833 −74.7* −2,559*
(1,055; 0 to 4,654) (1,146; 0 to 5,616) (36,135; 0 to 159,353) (39,232; 0 to 192,292) (−146.7 to −2.8) (−5,022 to −96)
Total 37,170 43,615 −6,445
(44,351; 3,713 to 231,733) (49,806; 3,723 to 256,182) (−9,522 to −3,368)
t-test p = 0.036*
MWU p = 0.010*
Sources of price information: hospital admissions in primary health service: variable cost; hospital admissions in other health services; acute hospital $1,065/night, rehabilitation hospital $751/night; Non-Medicare
claims: variable; physiotherapy: $48.50/visit boccupational therapy: $42.29/visit bspeech therapy: $46.59/visit bother allied health: $47.02/visit bcommunity nurse: $79.69/visit bPharmaceutical Benefits Scheme (PBS)
claims: variable; over–the-counter medications: variable; formal and informal carers: $34.24/hourb.
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service utilization data because the self-reported data
were checked against both the Medicare and primary
health service data. Where we had recorded the same
services, these were removed from the self-reported
data. For example, General Practitioner community visits
were reported in both the self-reported and Medicare
data, hence they were removed from the self-reported
data prior to the final analyses. The number and type of
non-Medicare health care visits, over-the-counter medi-
cations and the assistance of carers were also collected.
Carers included community paid carers (for example a
patient care attendant) and informal unpaid carers (for
example a family member).
Costing method
All costs were reported as 2012/2013 Australian dollars
(AUD$) (international currency conversion available
http://www.xe.com/currencyconverter/#converter [11]).
Administrative cost data collected for the primary health
service, Medicare and PBS covered three financial years.
Inflation rates of 3.7% and 7.2% respectively, were ap-
plied to the 2010/2011 and 2011/2012 data consistent
with the health care inflation rate of the national Con-
sumer Price Index [12].
Self-reported health service utilization costs for hos-
pital admissions outside of the primary health service
were calculated as an average cost per day, based on
data from the primary health service for acute and re-
habilitation admissions in 2012/2013. Out-of-pocket
costs were included in the charges reported in the Medi-
care data for medical and non-medical services and
pharmaceuticals. The cost of non-Medicare health care
services was based on charges for community allied health
services from the Victorian Transport Accident Commis-
sion [13]. Over-the-counter medications were costed ac-
cording to the actual drug used (Tables 1 and 2) [14].
Informal (unpaid) care was costed using the total hours re-
ported by patients multiplied by the hourly rate for a com-
munity health care attendant, to represent the true resource
cost of an equivalent formal health care professional.
Clinical outcomes measures
The EuroQol (EQ-5D-3L) questionnaire [15,16] was
used to measure patient health related quality of life and
was reported as a utility index score. A MCID in quality
of life was based on the recommendation to use half a
standard deviation of the baseline score [17]. Applied to
the quality of life utility index score in this study, an in-
crease of 0.18 represented a MCID in quality of life [4].
Functional independence was measured using the FIM
[18] administered by credentialed assessors. An increase
in the FIM score of 22 points (scores range from 18,
lowest function, to 126, highest function) was consideredto be a MCID in functional independence based on pre-
vious literature [19]. Both outcome measures were ad-
ministered on admission (baseline) and 6 and 12 months
following discharge from rehabilitation by assessors
blind to group allocation.
Statistical analysis
Mean cost difference was determined between the two
groups using an independent t-test at 6 months and at
12 months [20]. Cost data in an economic evaluation is
typically positively skewed and this is often due to a
small number of patients with high costs, although with
samples of greater than 150 participants it is reported
that the t-test is generally robust [21]. To acknowledge
the potential for skewed cost data, we have presented
the mean, SD and range for all cost data, as well as the
p-value for the t-test and the non-parametric equivalent,
the Mann–Whitney U test for total costs at 6 and
12 months. Between group differences in the quality of
life utility score and the functional independence score
were calculated with analysis of covariance (ANCOVA)
using the baseline score as covariate [22,23]. To further
address the potential for a skewed distribution of costs
and outcomes, relative risks (RRs) were used to calculate
the proportion of participants achieving a MCID in the
quality of life utility score and the functional independ-
ence score at 6 and 12 months following discharge [4].
Analysis was completed using intention-to-treat princi-
ples. Missing clinical outcome data and resource use
(due to non-consent for the release of Medicare and PBS
data or failure to complete the health utilization question-
naire at 6 or 12 months) were managed using a multiple
imputation method via chained equations imputation gen-
erating 5 imputed datasets [4,24]. Where participants had
died (confirmed by the next of kin at the 6 or 12 month
survey), they were included in the analyses, with total
costs weighted by time in the study. As the exact date of
death was unknown, the last date of service from the
Medicare data was used as a proxy. For example, if a death
was confirmed at the 12 month survey, and the last Medi-
care service was at 9 months, it was assumed that the per-
son participated in 75% of the follow up period, and costs
were weighted at .75. Incident rate ratios (IRR) were ana-
lysed for each of the resources in the follow up period to
report the difference in event rate between the control
and intervention groups.
Incremental cost effectiveness ratios (ICERs) and their
associated confidence intervals (CIs) for quality of life util-
ity and functional independence scores were calculated at
the sample level using the bootstrap method (5000 repeti-
tions) [25]. Individual ICERs were used to generate confi-
dence ellipses and cost effectiveness acceptability curves
(CEACs), using the central limit theorem, to illustrate cost
effectiveness across a range of willingness-to-pay values
Brusco et al. BMC Health Services Research  (2015) 15:165 Page 8 of 15[25]. The use of either the central limit theorem or the
bootstrapping method is appropriate to obtain uncertainty
around the mean difference when there is a moderate to
large sample size (n > 50), even when data are highly
skewed [25]. While the ellipses provide important infor-
mation relating to the statistical significance of the inter-
vention under review, the CEACs allow comparison
between different interventions. The ICER for the quality
of life utility score represents the cost per QALY gained.
The ICER for a one point change in the functional inde-
pendence score was multiplied to report the cost differ-
ence for a 22 point change in the functional independence
score, representing the marginal cost for a MCID in func-
tional independence.
Analyses were completed with IBM SPSS Statistics
Version 21 [26], STATA Version 12 [27] and the ICER,
CI, CI ellipse and CEAC were completed with software
in Microsoft Excel (spreadsheet available from Nixon
RM, Wonderling D, Grieve RD. 2010) [25]. All statis-
tical tests were conducted at a 5% level of significance
and reported with 95% confidence intervals (CI) unless
otherwise stated.
Sensitivity analysis
A number of sensitivity analyses were performed on the
total cost at 6 and 12 months. Two assumptions were made
for informal care; the first was to reduce the self-reported
amount by 50%, the second was to remove it altogether.
Fifty percent meant that the hours were capped at 12 hours
per day representative of a nursing shift. Removing informal
care was to allow comparison with previous literature,
where the inclusion of informal care is inconsistent, re-
ported in less than 10% of cost utility analyses [28,29].
Data from the self-reported health service utilization
questionnaire were adjusted to address the uncertainty of
recall bias. To determine the direction and amount of ad-
justment, we compared community General Practitioner
(GP) visits recorded in the Medicare administrative data to
self-reported data for those participants who were alive at
12 months, had completed both the 6 and 12 month ques-
tionnaires and for whom we had 12 months of Medicare
data. In addition, self-reported health service utilization
data were removed so that only administrative data from
the primary health service and Medicare were included, to
account for unpredictable variability in self reporting.
Statement of ethics approval
The study obtained ethics approval from Eastern Health
Research and Ethics Committee (reference number E58
09/10) and La Trobe University Human Research Ethics
Committee (reference number FHEC10/14), including
participant consent to meet requirements for Medicare
and PBS data. All patients gave informed written con-
sent prior to taking part.Results
Participants
A total of 996 patients were randomized to the control
group (n = 500) or the intervention group (n = 496) with
the flow of patients through the trial reported elsewhere
[4]. Patients had a mean age of 74 years (standard devi-
ation (SD) 13) and 631 (63%) were women. The groups
appeared similar for diagnosis and co-morbidities and
included 581 (58%) with an orthopedic diagnosis, and
203 (20%) with a neurological diagnosis.
At 12 months, 101 participants had died (intervention
group n = 52, control group n = 49) and at 6 months, 65
participants had died (intervention group n = 31, control
group n = 34). At 12 months, 82% (n = 812) of the total
participants were available for follow up and had com-
pleted the health service utilization questionnaire (inter-
vention group n = 401, control group n = 411). Of the
812 participants, there were 460 living at home inde-
pendently (intervention group n = 231, control group n
= 229) and a further 229 living at home with the support
of formal or informal carers (intervention group n = 114,
control group n = 115).
Values were imputed for the missing data from the 83
participants (8%) who were alive and did not complete
the health service questionnaire at 12 months, and for
the 52 participants who did not consent to Medicare
and PBS data (5%). Administrative data were available
from the primary health service for all participants
(100%) for the period between the initial rehabilitation
admission and 12 months following discharge from
rehabilitation.
Cost and utilization data
The mean total cost for the initial rehabilitation admis-
sion and the 12 months following discharge from re-
habilitation was $61,859 (SD 79,798) for the intervention
group and $68,184 (SD 82,922) for the control group,
with a mean cost difference of -6,325 (95% CI −16,730
to 4,081; t test p = 0.23 and MWU p = 0.06) in favor of
the intervention group (Table 1). The mean total cost
for the initial rehabilitation admission and the 6 months
following discharge from rehabilitation was $37,170 (SD
44,351) for the intervention group and $43,615 (SD
49,806) for the control group, with a mean cost
difference of -6,445 (95% CI −9,522 to −3,368; t test p =
0.04 and MWU p = 0.01) in favor of the intervention
group (Table 2).
Mean hospital length of stay for all admissions to the pri-
mary health service during the 12 months following dis-
charge from rehabilitation was 10.3 days (SD 24.5; n = 496)
for the intervention group and 15.2 days (SD 37.4; n = 500)
for the control group, with a mean difference of −4.9 days
(95% CI −9.0 to −0.9; p = 0.02) in favor of the intervention
group (Table 1). The intervention group had an observed
Brusco et al. BMC Health Services Research  (2015) 15:165 Page 9 of 15event rate of 29% (IRR 0.71; 95% CI 0.52 to 0.96) less than
the control group for the risk of readmission to either the
primary health service or to another health service over the
12 months following discharge, and an event rate of 34%
(IRR 0.66; 95% CI 0.45 to 0.98) less than the control group
over 6 months following discharge. Cost and utilization
data relating to other health care services, Medicare, PBS
and self-reported health utilization data included in the
economic evaluation are reported in Tables 1 and 2. For
most individual health services there was a pattern of less
resource utilization and less cost that favored the interven-
tion group, although these differences were not statistically
significant. Excluding readmission to either the primary
health service or to another health service, all other health
services had a non-significant difference in the observed
event rate between the control and the intervention groups,
for the 6 and 12 month periods following discharge.
Clinical outcomes measures
Difference between the intervention and control groups
for the health related quality of life utility index score
was non-significant between admission and 12 months
following discharge from rehabilitation (MD 0.01, 95%
CI −0.04 to 0.05; p = 0.77) and at 6 months following
discharge (MD 0.03, 95% CI −0.01 to 0.08; p = 0.15)
(Table 3). At 12 months, participants in the intervention
group were 11% more likely to achieve a MCID in health
related quality of life utility index score (RR 1.11; 95% CI
1.00 to 1.24) and at 6 months they were 19% more likely
to do so (RR 1.19; 95% CI 1.06 to 1.34), compared to the
control group. The difference between the intervention
and control groups for the functional independence
score was non-significant between admission and
12 months following discharge from rehabilitation (MD
1.3, 95% CI −0.9 to 3.5; p = 0.24), although the interven-
tion group had a higher positive change between admission
and 6 months following discharge (MD 2.0, 95% CI 0.0 to
4.0; p = 0.05) (Table 3). Participants in the intervention
group were not more likely to achieve a MCID in their func-
tional independence score at either 12 months (RR 1.07;
95% CI 0.96 to 1.20) or at 6 months following discharge (RR
1.06; 95% CI 0.94 to 1.19) compared to the control group.
Incremental cost effectiveness ratio
In summary, the results indicate that the intervention is
associated with lower costs and improved health out-
comes. The ICER and associated 95% CIs may be inter-
preted as follows; each of the ICERs are positive which
represents a cost saving to the health system. When the
lower value of the 95% CI is negative, this represents a
potential additional cost, and when the lower value of
the 95% CI is positive, this represents a potential cost
saving. Each of the upper values of the reported 95% CIs
are positive which represents a potential cost saving.The ICER for the initial rehabilitation admission and
the 12 months following discharge from rehabilitation
reported a non-significant cost saving of $282,144
(95% CI −1,074,914 to 1,520,885) per QALY gained for
the intervention group compared to the control group.
The ICER for this same period reported a non-
significant cost saving of $10,199 (95% CI −63,526 to
81,511) for a one point change in the functional inde-
pendence score for the intervention group compared
to the control group; or a cost saving of $200,797 (95%
CI −1,300,355 to 1,572,604) for a MCID in functional
independence for the intervention group compared to
the control group.
The ICER was statistically significant at 6 months fol-
lowing discharge showing a cost saving of $112,320 (95%
CI 6,556 to 336,631) per QALY gained for the interven-
tion group compared to the control group. The ICER for
this same period reported a non-significant cost saving
of $2,540 (95% CI −14,972 to 24,597) for a one point
change in the functional independence score for the
intervention group compared to the control group, or a
non-significant cost saving of $99,580 (95% CI −254,401
to 543,098) for a MCID in functional independence for
the intervention group compared to the control group.
The ICER point estimation and the confidence interval
ellipses (50%, 75% and 95%) for the 6 and 12 months fol-
lowing discharge from rehabilitation are presented in
Figure 1. The confidence ellipses show that most of the
50%, 75% and 95% confidence intervals sit within the
bottom right quadrant of the cost effectiveness plane
and only a small portion falls in the upper right or lower
left quadrants [30].Cost effectiveness acceptability curve
For the initial rehabilitation admission and in the
12 months following discharge from rehabilitation, the
curves were relatively flat. For a willingness to pay of
$50,000 there was 98% certainty of cost effectiveness for
a QALY gained or for a MCID in functional independ-
ence (Figure 2). Alternatively for this same time period,
for a willingness to pay of zero dollars, there was 97%
certainty of cost effectiveness for a QALY gained or for a
MCID gained in functional independence.
For the initial rehabilitation admission and in the
6 months following discharge from rehabilitation the
curves were relatively flat. For a willingness to pay of
$23,000 there was almost 100% certainty of cost effect-
iveness for a QALY gained or for a MCID gained in
functional independence (Figure 2). Alternatively for
this same time period, for a willingness to pay of zero
dollars, there was 98% certainty of cost effectiveness
for a QALY gained or for a MCID gained in functional
independence.
Table 3 Outcome measures on admission, 6 and 12 months
Groups Difference between groups
Admission Month 6 following discharge Month 12 following discharge Month 6 Month 12
Mean (SD; range) Mean (SD; range) Mean (SD; range)




(n = 496) (n = 500) (n = 496) (n = 500) (n = 496) (n = 500)
FIM total 84 84 109 107 109 108 2.0 1.3
(19; 19 to 119) (20; 0 to 124) (17; 22 to 126) (19; 21 to 126) (17; 19 to 126) (19; 21 to 126) (0.0 to 4.0) (−0.9 to 3.5)
p = 0.05* p = 0.24
EQ-5D-3L utility index 0.32 0.37 0.63 0.61 0.64 0.64 0.03 0.01
(0.35; −0.59 to 1.00) (0.35; −0.59 to 1.00) (0.36; −0.35 to 1.00) (0.37; −0.43 to 1.00) (0.39; −0.59 to 1.00) (0.34; −0.59 to 1.00) (−0.01 to 0.08) (−0.04 to 0.05)
p = 0.15 p = 0.77
















Figure 1 a-d Confidence ellipses for intervention versus control for the incremental cost (vertical axis AUD$2012/13) per incremental outcome
gained (horizontal axis). (a) Inpatient admission and 12 months following discharge for incremental cost per quality adjusted life year (QALY) gained.
(b) Inpatient admission and 12 months following discharge for incremental cost per minimal clinically important difference (MCID) in function.
(c) Inpatient admission and 6 months following discharge for incremental cost per quality adjusted life year (QALY) gained. (d) Inpatient admission
and 6 months following discharge for incremental cost per minimal clinically important difference (MCID) in function.
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Reducing the amount of informal care by 50% over the
12 months following discharge from rehabilitation resulted
in a non-significant mean cost difference of -5,518 (95% CI
−12,155 to 1,119; p = 0.10) in favor of the intervention
group. Reducing the amount to zero resulted in a
significant mean cost difference of -4,711 (95% CI −9,132 to
−290; p = 0.04) in favor of the intervention group (Table 4).
Of the 752 participants with complete data at 12 months,
there were 9,419 self-reported community GP visits com-
pared to 10,855 visits recorded by Medicare for claims
for GP services. This suggests under reporting of self-
reported primary health care services. Based on these data,
the number of self-reported health services utilized in the
12 months following discharge from rehabilitation was
inflated by 15%. This resulted in a non-significant mean
cost difference of -6,660 (95% CI −18,346 to 5,026;
p = 0.26) in favor of the intervention group; reducing the
amount to zero resulted in a significant mean cost
difference of -4,089 (95% CI −6,165 to −2,012; p = 0.05) in
favor of the intervention group (Table 4).
The sensitivity analyses were repeated for the period
between the initial rehabilitation admission and in the
6 months following discharge with similar findings that all
significantly favored the intervention group (Table 4).Discussion
From a health system perspective inclusive of private
costs, the provision of a Saturday rehabilitation service
to inpatients in addition to Monday to Friday, improved
QALYs as well as functional status, and reduced costs
compared with usual Monday to Friday care at both 6
and 12 months following discharge from rehabilitation.
One explanation for why the intervention was cost effect-
ive at 6 months and possibly cost effective at 12 months
was that participants who received the additional Saturday
rehabilitation were discharged at a higher level of functional
independence [4] and therefore were equipped to live
independently in the community with less dependence on
community health services. An interpretation is that the
quantity of inpatient rehabilitation does matter; for the pa-
tient population in our trial most functional gains occurred
during the inpatient stay, with minimal gains following
discharge. For example in the current trial, participants in
the intervention group had significant gains in their FIM
score from admission to discharge (26%), with lesser gains
from discharge to 6 months (2%) and no change from 6 to
12 months [4]. These results support previous studies that
report most functional gains occur in the initial rehabilita-
tion period and after this functional status largely remains
the same [31,32]. Health service resource and cost data that
a b
c d
Figure 2 a-d Cost effectiveness acceptability curve for intervention versus control for the probability of cost effectiveness (vertical axis) versus a range
of cost effectiveness willingness to pay values (AUD$2012/13) per incremental outcome gained (horizontal axis). (a) Inpatient admission and 12 months
for incremental cost per quality adjusted life year (QALY) gained. (b) Inpatient admission and 12 months for incremental cost per minimal clinically
important difference (MCID) in function. (c) Inpatient admission and 6 months for incremental cost per quality adjusted life year (QALY) gained.
(d) Inpatient admission and 6 months for incremental cost per minimal clinically important difference (MCID) in function.
Brusco et al. BMC Health Services Research  (2015) 15:165 Page 12 of 15favored the intervention group were realized between
admission and 6 months (p = 0.04) but not between 6 and
12 months following discharge.
During the initial inpatient rehabilitation admission there
was a potential cost saving from a reduction in length of
stay. However, this needs to be considered in the context of
the direct additional costs to run a Saturday rehabilitation
program [3]. The additional resources required for a Saturday
service include therapist time, space, equipment and
consumable items. On average these additional resource
costs for providing the additional Saturday rehabilitation
service were less than $200 per admission, in comparison
with the overall observed saving of over $1,600 per
admission [3]. This demonstrates that the additional costs
of running the Saturday service were offset by a substantial
saving over the duration of the rehabilitation admission.
From admission to 12 months following discharge most
of the savings to the health system occurred from the
reduction in hospital readmissions, with no significant
differences in community care services, including medical
services. There was no observed cost shift into the commu-
nity; in fact there was an ongoing cost saving to the
community that included reduced readmissions to the pri-
mary and other health services. A cost shift may involvereporting false “savings” based on redistributing the cost
from one health service into the broader community health
systems [33]; this would be evident if the intervention
group had reduced health service utilization in the inpatient
stay, but had higher health service utilization across any or
all of the other health services in the 12 months following
discharge. This was not the case. The intervention group
had reduced health service utilization during their inpatient
stay with ongoing reduced health service utilization in the
12 months following discharge. These results are consistent
with other inpatient rehabilitation intervention studies that
report that cost savings during the initial rehabilitation
period are associated with a reduced length of stay, and
with no cost shift following discharge [8,34].
Another example of cost shift is the reliance on informal
care once the patient is discharged from the rehabilitation
facility. That is, the cost of care is shifted from the health
system into the household and it is frequently family and
friends who provide the unpaid care. In addition to this
being reported as a potential cost shift, there needs to be
consideration of the burden that this may place on the
household [35]. In Australia, it is estimated that the annual
cost of replacing informal care with paid care is $4.8 billion
[36]. Despite this substantial cost to society, support for the
Table 4 Sensitivity analysis for the total costs between the initial inpatient admission and 6 or 12 months following
discharge (AUD$2012/13)
Mean cost per patient for the period between
the initial inpatient admission and 6 or




Intervention Control Intervention minus control (95% CI)
(n = 496) (n = 500)
12 months
Mean total cost base case 61,859 68,184 −6,325
(79,798; 4,845 to 463,656) (82,922; 4,845 to 463,656) (−16,730 to 4,081) p = 0.234
Informal care reduced by 50% 47,774 53,292 −5,518
(49,820; 4,656 to 271,517) (53,891; 4,845 to 279,795) (−12,155 to 1,119) p = 0.103
Informal care reduced to 0 33,689 38,400 −4,711
(31,704; 4,656 to 222,674) (37,145; 4,845 to 225,707) (−9,132 to −290) p = 0.037*
Health service utilization
data increased by 15%
66,788 73,448 −6,660
(89,786; 4,678 to 458,171) (92,978; 4,862 to 522,237) (−18,346 to 5,026) p = 0.264
Health service utilization
data reduced to 0
29,001 33,089 −4,089
(28,812; 2,652 to 222,805) (34,562; 4,246 to 225,016) (−6,165 to – 2,012) p = 0.049*
6 months
Mean total cost base case 37,170 43,615 −6,445
(44,351; 3,713 to 231,733) (49,806; 3,723 to 256,182) (−9,522 to −3,368) p = 0.036*
Informal care reduced by 50% 30,533 35,698 −5,165
(30,043; 3,713 to 193,317) (35,204; 3,723 to 187,463) (−7,301 to −3,030) p = 0.016*
Informal care reduced to 0 23,896 27,782 −3,886
(22,186; 3,713 to 183,970) (27,729; 3,723 to 184,894) (−5,641 to −2,131) p = 0.018*
Health service utilization
data increased by 15%
39,569 46,464 −6,894
(49,366; 3,713 to 254,588) (55,146; 3,713 to 285,570) (−10,309 to −3,480) p = 0.043*
Health service utilization
data reduced to 0
21,175 24,621 −3,446
(20,203; 2,652 to 179,677) (26,116; 2,638 to 184,543) (−4,970 to −1,922) p = 0.024*
*p ≤ 0.05. adeath weights have been applied to this data set to represent time in the study pertaining to patient death.
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consistent [28,29,37,38]. The scope of this economic evalu-
ation included the utilization of informal care which repre-
sented 43% of the total costs. Sixteen percent of our
participants had survived a stroke and the cost of informal
care was within the range of costs reported by other studies
with a stroke cohort where informal care represented 4% to
55% of the total costs [7,8,39]. Contributing to this variation
could be different methods for costing informal care, such
as allotting one-third the cost of the average national wage
[39], price equivalence to the cost of hostel care [7], the
minimum wage [8], the cost of a home help worker [8] or
our method of uncapped actual daily hours valued at that
of an equivalent paid formal carer. The variation in includ-
ing the cost of informal care, together with the variation of
assumptions of costing of informal care, supported our sensi-
tivity analyses that varied, and removed the cost of informal
care. When the amount of informal care was reduced
to zero, the observed difference in total cost at 12 monthsfollowing discharge between the intervention and control
groups was significant and in favor of the intervention group.
This economic evaluation has implications for both
health service managers, and policy makers. The provision
of an additional Saturday inpatient rehabilitation service
provided benefits that reduced short term costs to the
health service and reduced the medium term costs across
the health system including a reduction in hospital read-
missions that could potentially free up inpatient beds [40].
In support of this, participants who received additional
Saturday rehabilitation had a mean reduction of 4.9 days
(95% CI −9.0 to −0.9; p = 0.02; IRR 0.71; 95% CI 0.52 to
0.96) in admission to hospital in the 12 months following
discharge from rehabilitation compared with the control
group. The implication is a win-win intervention for the
health service, the health system and the patient. In
Australia, health care is funded by the government at both
national and state levels, as well as by private insurers. At
the national level, primary health care is publically funded
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care services (e.g. a general practitioner or medical special-
ist), whereas the state government is responsible for the
provision of public hospital services, such as the rehabilita-
tion inpatient admissions included in this clinical trial [41].
Funding for public hospital acute and rehabilitation services
is via the Australian government and based on a single
episode of care; as such readmissions that occur in the 12
month follow up period after the initial rehabilitation hos-
pital episode in this clinical trial are funded as a separate
episode of care. Therefore, under output based funding
public hospitals have an incentive to discharge acute (in-
cluding acute phase rehabilitation) patients as early as pos-
sible. This contrasts with the private system where private
insurance funding may be a per diem amount or a fixed
amount for the episode. Theoretically, as the results of our
trial show a reduction in total cost, both public and private
hospitals should be willing to implement weekend acute re-
habilitation services. However, cost savings may be realised
at the broader hospital level while the spending and staffing
decisions may be realised at the department level, so with-
out resource reallocation and collaboration, the provision
of a weekend service may be difficult to implement.
The strengths of this economic evaluation are that it was
completed alongside a blinded, fully powered randomized
controlled trial and it used an appropriate alternative inter-
vention, as only 30% of Australian rehabilitation inpatient
health services offer a weekend physiotherapy service [42].
Other strengths included access to complete clinical cost
data on all patients across the primary health service, Medi-
care and PBS administrative data as well as the inclusion of
informal care. A range of rehabilitation diagnoses and
patients with a language other than English as their first
language were included in the trial representing a general
rehabilitation population. A limitation of using a self-
reported health service utilization tool is recall bias; how-
ever, the sensitivity analysis addressed this by varying the
value of this self-reported data. The wide and uneven distri-
bution of the CIs around the ICER are difficult to interpret
[43,44], however they have been reported as the sample size
is large [25] and the non-parametric bootstrap method was
used [43]. The CI ellipses for the ICERs show that most of
the 75% and 95% CIs fall within the bottom right hand
quadrant. This suggests that the intervention is dominant
over the comparator of usual care. This study did not
include the wider economic impact from a societal perspec-
tive including factors such as return to work, the costs of
travel or the cost of nursing home placement. The impact
on return to work for this study has been reported else-
where [6]. Therefore, we are confident that the results are
generalizable across public acute phase inpatient rehabilita-
tion settings. There were minor variations to the trial
protocol. These included the use of multiple imputation
rather than the carry forward technique for missing data,consistent with recent recommendations [24], as well as a
reduced data collection period due to a higher than
expected rate of participant recruitment. Future research
may focus on translation research designed for successful
and sustained implementation of this additional Saturday
rehabilitation service.
Conclusion
From a health system perspective inclusive of private costs
and informal care, the provision of a rehabilitation service to
inpatients on a Saturday in addition to Monday to Friday
compared to Monday to Friday rehabilitation alone, is likely
to have sustained cost savings per QALY gained and for a
MCID in functional independence during the inpatient stay
and up to 12 months following discharge from rehabilitation.
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